DRAGON trial

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

BHP explores a potential $2 billion sale of Chilean desalination and electricity transmission assets supporting its major copper operations. Representative image.

BHP (ASX: BHP) explores $1.5-$2bn sale of Chilean desalination plant and power lines

Vodafone shares surge after Xavier Niel’s Vega agrees to acquire e&’s 16.21 percent stake in a £4.4 billion transaction. Representative image.

Vodafone (LSE: VOD) jumps 12% as Xavier Niel’s Vega buys e&’s 16.21% stake for £4.4bn

GlobalWafers and Micron Technology expand United States semiconductor supply capacity through a $500 million financing and 10-year silicon wafer agreement. Representative image.

GlobalWafers locks in $500m Micron financing and 10-year Sherman wafer supply pact

Ukraine’s new long-range strike command intensifies its campaign against Russian oil refineries, fuel infrastructure and wartime logistics networks. Representative image.

Ukraine’s drone war enters new phase with dedicated command targeting Russia

Belite Bio wins UK MHRA nod to file conditional marketing application for tinlarebant in Stargardt disease

Find out how Belite Bio gained UK MHRA backing to file a conditional marketing application for tinlarebant, advancing the first potential therapy for Stargardt disease.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

November 3, 2025